Ipsen

Works in Cardiovascular · Dermatology · Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Psychiatry · Renal & urogenital · Respiratory · Women's health

Ipsen is a clinical trial sponsor. It has 35 active clinical trials with 9,342 planned participants, across 14 therapeutic areas. Since 2021 it has completed 78 trials and stopped 20 early.

Trial track record · since 2021

35Active trials9,342 planned participants
78Completed57 with results posted
20Stopped early20% of finished trials

Pipeline · 35 active trials

StageTrialStatus

On the market

6 approved drug applications with a product on the market.

Questions about Ipsen

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-05.

Approve Suite is not affiliated with Ipsen.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.